1-(6,7-BIS(DIFLUOROMETHOXY)NAPHTHALEN-2-YL)-2-METHYL-1-(1H-1,2,3-TRIAZOL-4-YL)PROPAN-1-OL AS INHIBITOR OF CYP17 FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES LIKE PROSTATE CANCER

摘要

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.